Pseudoephedrine Hydrochloride, Cetirizine Dihydrochloride

7 trials 3 recruiting RRespiratory

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

3 Recruiting

3 Completed trials

6 Sponsors

13 Countries

Phase III

Phase II

Phase I (FiH)

Phase III: 1 Phase II: 3 Phase I (FiH): 3

Oversight events:

6 temporary halts 1 unexpected event across 1 trial

View oversight register →

Indications tested

Acute myeloid leukaemia refractory 1 IgA nephropathy 1 Crigler-Najjar syndrome 1 Blastic plasmacytoid dendritic cell neoplasia 1 Myelodysplastic syndrome 1 B-cell type acute leukaemia 1 Multiple sclerosis 1

Sponsors using this IMP

Moderna Inc. 2 Biogen Idec Research Limited 1 Genethon 1 Novo Nordisk A/S 1 Region Uppsala 1 Sanofi-Aventis Recherche & Developpement 1

All trials

7 total

HiHat trial Pending

2024-519700-28-01 Phase II 1 country Region Uppsala
A study to investigate the safety and efficacy of mRNA-3927 in participants with genetically confirmed propionic acidemia Recruiting

2022-502910-10-00 Phase I (FiH) 4 countries Moderna Inc.
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) ( PREVAIL ) Recruiting

2024-519345-30-00 Phase III 11 countries Biogen Idec Research Limited
Efficacy and safety trial of GNT0003 following imlifidase pre-treatment in participants aged 16 years and older with severe Crigler-Najjar s… Recruiting

2023-510405-18-00 Phase II 1 country Genethon
A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin a… Ended

2022-502605-15-00 Phase II 7 countries Novo Nordisk A/S
First-in-human study of SAR443579 infusion in male and female children and adult participants with relapsed or refractory acute myeloid leuk… Ended

2023-508357-58-00 Phase I (FiH) 2 countries Sanofi-Aventis Recherche & Developpement
A dose-finding study to evaluate mRNA-3210 in participants with phenylketonuria Ended

2023-506963-32-00 Phase I (FiH) 3 countries Moderna Therapeutics Inc.

Showing 1–7 of 7 trials

← All drugs A–Z